0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-7224
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Spine Biologics Market Insights Forecast to 2025
BUY CHAPTERS

Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-7224
Report
May 2025
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Spine Biologics Market Size

In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

Spine Biologics Market

Spine Biologics Market

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.
North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.
In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Spine Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Biologics.
The Spine Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spine Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spine Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Spine Biologics Market Report

Report Metric Details
Report Name Spine Biologics Market
CAGR 3.3%
Segment by Type
Segment by Application
  • Anterior Cervical Discectomy and Fusion
  • Posterior Lumbar Interbody Fusion
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Spine Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spine Biologics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Spine Biologics Market?

Ans: Global top five manufacturers hold a share over 75%.

What is the Spine Biologics Market share by type?

Ans: In terms of product, Bone Graft is the largest segment, with a share over 55%.

Who are the main players in the Spine Biologics Market report?

Ans: The main players in the Spine Biologics Market are Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex

What are the Application segmentation covered in the Spine Biologics Market report?

Ans: The Applications covered in the Spine Biologics Market report are Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion, Others

What are the Type segmentation covered in the Spine Biologics Market report?

Ans: The Types covered in the Spine Biologics Market report are Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), BMAC (Bone Marrow Aspirate Concentrate)

Recommended Reports

Spinal Devices Market

Biologics & Therapies

Musculoskeletal Treatments

Market trends :

Topic Trends
Global the spine biologics market is experiencing steady growth driven by increased adoption of bone grafts and biologic substitutes in spinal surgeries, with north america maintaining a dominant market share due to advanced healthcare infrastructure and high procedure volumes.
Type Bone Graft - bone grafts remain the most widely used spine biologics segment, accounting for over half of the market due to their established efficacy in spinal fusion procedures.
Application Posterior Lumbar Interbody Fusion - posterior lumbar interbody fusion continues to be the leading application for spine biologics, reflecting strong demand for minimally invasive and effective spinal fusion solutions.
Region North America - north america leads the global spine biologics market with over 60% share, supported by high adoption rates, technological advancements, and favorable reimbursement policies.
1 Study Coverage
1.1 Spine Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Spine Biologics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Market by Application
1.3.1 Global Spine Biologics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Spine Biologics Market Size Estimates and Forecasts
2.1.1 Global Spine Biologics Revenue 2020-2031
2.1.2 Global Spine Biologics Sales 2020-2031
2.2 Spine Biologics Market Size by Region: 2024 Versus 2031
2.3 Spine Biologics Sales by Region (2020-2031)
2.3.1 Global Spine Biologics Sales by Region: 2020-2025
2.3.2 Global Spine Biologics Sales Forecast by Region (2026-2031)
2.3.3 Global Spine Biologics Sales Market Share by Region (2020-2031)
2.4 Spine Biologics Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Spine Biologics Revenue by Region: 2020-2025
2.4.2 Global Spine Biologics Revenue Forecast by Region (2026-2031)
2.4.3 Global Spine Biologics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Spine Biologics Sales by Type (2020-2031)
3.1.1.1 Global Spine Biologics Sales Volume by Type (2020-2031)
3.1.1.2 Global Spine Biologics Sales Market Share by Type (2020-2031)
3.1.2 Global Spine Biologics Revenue by Type (2020-2031)
3.1.2.1 Global Spine Biologics Revenue by Type (2020-2031)
3.1.2.2 Global Spine Biologics Revenue Market Share by Type (2020-2031)
3.1.3 Spine Biologics Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Spine Biologics Sales by Application (2020-2031)
3.2.1.1 Global Spine Biologics Sales Volume by Application (2020-2031)
3.2.1.2 Global Spine Biologics Sales Market Share by Application (2020-2031)
3.2.2 Global Spine Biologics Revenue by Application (2020-2031)
3.2.2.1 Global Spine Biologics Revenue by Application (2020-2031)
3.2.2.2 Global Spine Biologics Revenue Market Share by Application (2020-2031)
3.2.3 Spine Biologics Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Bone Graft of Spine Biologics Revenue Market Share by Application
3.3.2 Bone Graft Substitute of Spine Biologics Revenue Market Share by Application
3.3.3 Platelet Rich Plasma (PRP) of Spine Biologics Revenue Market Share by Application
3.3.4 BMAC (Bone Marrow Aspirate Concentrate) of Spine Biologics Revenue Market Share by Application
4 Global Spine Biologics by Manufacturers
4.1 Global Top Spine Biologics Manufacturers by Sales (2020-2025)
4.1.1 Global Spine Biologics Sales by Manufacturer (2020-2025)
4.1.2 Global Spine Biologics Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Spine Biologics Manufacturers by Revenue (2020-2025)
4.2.1 Global Spine Biologics Revenue by Manufacturer (2020-2025)
4.2.2 Global Spine Biologics Revenue Share by Manufacturer (2020-2025)
4.3 Global Spine Biologics Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Spine Biologics Manufacturers Covered: Ranking by Revenue
4.4.2 Global Spine Biologics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Spine Biologics Manufacturing Base Distribution, Product Type
4.5.1 Spine Biologics Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Spine Biologics Market
4.5.3 Manufacturers Spine Biologics Product Type and Application
4.5.4 Bone Graft Market Sales of Spine Biologics by Manufacturer
4.5.5 Bone Graft Substitute Market Sales of Spine Biologics by Manufacturer
4.5.6 Platelet Rich Plasma (PRP) Market Sales of Spine Biologics by Manufacturer
4.5.7 BMAC (Bone Marrow Aspirate Concentrate) Market Sales of Spine Biologics by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Medtronic
5.1.1 Medtronic Company Information
5.1.2 Medtronic Description, Business Overview
5.1.3 Medtronic Spine Biologics Products Offered
5.1.4 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Medtronic Spine Biologics Sales by Product in 2024
5.1.6 Medtronic Spine Biologics Sales by Application in 2024
5.1.7 Medtronic Spine Biologics Sales by Geographic Area in 2024
5.1.8 Medtronic Recent Developments
5.2 Depuy Synthes
5.2.1 Depuy Synthes Company Information
5.2.2 Depuy Synthes Description, Business Overview
5.2.3 Depuy Synthes Spine Biologics Products Offered
5.2.4 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Depuy Synthes Spine Biologics Sales by Product in 2024
5.2.6 Depuy Synthes Spine Biologics Sales by Application in 2024
5.2.7 Depuy Synthes Spine Biologics Sales by Geographic Area in 2024
5.2.8 Depuy Synthes Recent Developments
5.3 Stryker Corporation
5.3.1 Stryker Corporation Company Information
5.3.2 Stryker Corporation Description, Business Overview
5.3.3 Stryker Corporation Spine Biologics Products Offered
5.3.4 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Stryker Corporation Spine Biologics Sales by Product in 2024
5.3.6 Stryker Corporation Spine Biologics Sales by Application in 2024
5.3.7 Stryker Corporation Spine Biologics Sales by Geographic Area in 2024
5.3.8 Stryker Corporation Recent Developments
5.4 Nuvasive
5.4.1 Nuvasive Company Information
5.4.2 Nuvasive Description, Business Overview
5.4.3 Nuvasive Spine Biologics Products Offered
5.4.4 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Nuvasive Spine Biologics Sales by Product in 2024
5.4.6 Nuvasive Spine Biologics Sales by Application in 2024
5.4.7 Nuvasive Spine Biologics Sales by Geographic Area in 2024
5.4.8 Nuvasive Recent Developments
5.5 Zimmer Biomet
5.5.1 Zimmer Biomet Company Information
5.5.2 Zimmer Biomet Description, Business Overview
5.5.3 Zimmer Biomet Spine Biologics Products Offered
5.5.4 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Zimmer Biomet Spine Biologics Sales by Product in 2024
5.5.6 Zimmer Biomet Spine Biologics Sales by Application in 2024
5.5.7 Zimmer Biomet Spine Biologics Sales by Geographic Area in 2024
5.5.8 Zimmer Biomet Recent Developments
5.6 Orthofix International
5.6.1 Orthofix International Company Information
5.6.2 Orthofix International Description, Business Overview
5.6.3 Orthofix International Spine Biologics Products Offered
5.6.4 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Orthofix International Spine Biologics Sales by Product in 2024
5.6.6 Orthofix International Spine Biologics Sales by Application in 2024
5.6.7 Orthofix International Spine Biologics Sales by Geographic Area in 2024
5.6.8 Orthofix International Recent Developments
5.7 Globus Medical
5.7.1 Globus Medical Company Information
5.7.2 Globus Medical Description, Business Overview
5.7.3 Globus Medical Spine Biologics Products Offered
5.7.4 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Globus Medical Spine Biologics Sales by Product in 2024
5.7.6 Globus Medical Spine Biologics Sales by Application in 2024
5.7.7 Globus Medical Spine Biologics Sales by Geographic Area in 2024
5.7.8 Globus Medical Recent Developments
5.8 alphatec spine
5.8.1 alphatec spine Company Information
5.8.2 alphatec spine Description, Business Overview
5.8.3 alphatec spine Spine Biologics Products Offered
5.8.4 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.8.5 alphatec spine Spine Biologics Sales by Product in 2024
5.8.6 alphatec spine Spine Biologics Sales by Application in 2024
5.8.7 alphatec spine Spine Biologics Sales by Geographic Area in 2024
5.8.8 alphatec spine Recent Developments
5.9 K2M
5.9.1 K2M Company Information
5.9.2 K2M Description, Business Overview
5.9.3 K2M Spine Biologics Products Offered
5.9.4 K2M Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.9.5 K2M Spine Biologics Sales by Product in 2024
5.9.6 K2M Spine Biologics Sales by Application in 2024
5.9.7 K2M Spine Biologics Sales by Geographic Area in 2024
5.9.8 K2M Recent Developments
5.10 Exactech
5.10.1 Exactech Company Information
5.10.2 Exactech Description, Business Overview
5.10.3 Exactech Spine Biologics Products Offered
5.10.4 Exactech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Exactech Spine Biologics Sales by Product in 2024
5.10.6 Exactech Spine Biologics Sales by Application in 2024
5.10.7 Exactech Spine Biologics Sales by Geographic Area in 2024
5.10.8 Exactech Recent Developments
5.11 Wright Medical Technology
5.11.1 Wright Medical Technology Company Information
5.11.2 Wright Medical Technology Description, Business Overview
5.11.3 Wright Medical Technology Spine Biologics Products Offered
5.11.4 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Wright Medical Technology Spine Biologics Sales by Product in 2024
5.11.6 Wright Medical Technology Spine Biologics Sales by Application in 2024
5.11.7 Wright Medical Technology Spine Biologics Sales by Geographic Area in 2024
5.11.8 Wright Medical Technology Recent Developments
5.12 X-Spine
5.12.1 X-Spine Company Information
5.12.2 X-Spine Description, Business Overview
5.12.3 X-Spine Spine Biologics Products Offered
5.12.4 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.12.5 X-Spine Spine Biologics Sales by Product in 2024
5.12.6 X-Spine Spine Biologics Sales by Application in 2024
5.12.7 X-Spine Spine Biologics Sales by Geographic Area in 2024
5.12.8 X-Spine Recent Developments
5.13 Nutech
5.13.1 Nutech Company Information
5.13.2 Nutech Description, Business Overview
5.13.3 Nutech Spine Biologics Products Offered
5.13.4 Nutech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Nutech Spine Biologics Sales by Product in 2024
5.13.6 Nutech Spine Biologics Sales by Application in 2024
5.13.7 Nutech Spine Biologics Sales by Geographic Area in 2024
5.13.8 Nutech Recent Developments
5.14 Arthrex
5.14.1 Arthrex Company Information
5.14.2 Arthrex Description, Business Overview
5.14.3 Arthrex Spine Biologics Products Offered
5.14.4 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Arthrex Spine Biologics Sales by Product in 2024
5.14.6 Arthrex Spine Biologics Sales by Application in 2024
5.14.7 Arthrex Spine Biologics Sales by Geographic Area in 2024
5.14.8 Arthrex Recent Developments
6 North America
6.1 North America Spine Biologics Market Size YoY Growth 2020-2031
6.2 North America Spine Biologics Market Facts & Figures by Country
6.2.1 North America Spine Biologics Sales by Country (2020-2031)
6.2.2 North America Spine Biologics Revenue by Country (2020-2031)
6.3 North America Spine Biologics Sales by Type (2020-2025)
6.4 North America Spine Biologics Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Spine Biologics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Spine Biologics Market Facts & Figures by Region
7.2.1 Asia-Pacific Spine Biologics Sales by Region (2020-2031)
7.2.2 Asia-Pacific Spine Biologics Revenue by Region (2020-2031)
7.3 Asia-Pacific Spine Biologics Sales by Type (2020-2025)
7.4 Asia-Pacific Spine Biologics Sales by Application (2020-2025)
8 Europe
8.1 Europe Spine Biologics Market Size YoY Growth 2020-2031
8.2 Europe Spine Biologics Market Facts & Figures by Country
8.2.1 Europe Spine Biologics Sales by Country (2020-2031)
8.2.2 Europe Spine Biologics Revenue by Country (2020-2031)
8.3 Europe Spine Biologics Sales by Type (2020-2025)
8.4 Europe Spine Biologics Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Spine Biologics Market Size YoY Growth 2020-2031
9.2 Latin America Spine Biologics Market Facts & Figures by Country
9.2.1 Latin America Spine Biologics Sales by Country (2020-2031)
9.2.2 Latin America Spine Biologics Revenue by Country (2020-2031)
9.3 Latin America Spine Biologics Sales by Type (2020-2025)
9.4 Latin America Spine Biologics Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Spine Biologics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Spine Biologics Market Facts & Figures by Country
10.2.1 Middle East and Africa Spine Biologics Sales by Country (2020-2031)
10.2.2 Middle East and Africa Spine Biologics Revenue by Country (2020-2031)
10.3 Middle East and Africa Spine Biologics Sales by Type (2020-2025)
10.4 Middle East and Africa Spine Biologics Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Spine Biologics Supply Chain Analysis
11.2 Spine Biologics Key Raw Materials and Upstream Suppliers
11.3 Spine Biologics Clients Analysis
11.4 Spine Biologics Sales Channel and Sales Model Analysis
11.4.1 Spine Biologics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Spine Biologics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Spine Biologics Distributors
12 Spine Biologics Market Dynamics
12.1 Spine Biologics Industry Trends
12.2 Spine Biologics Market Drivers
12.3 Spine Biologics Market Challenges
12.4 Spine Biologics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Spine Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Spine Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Spine Biologics Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Spine Biologics Sales by Region (2020-2025) & (K Units)
 Table 5. Global Spine Biologics Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Spine Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Spine Biologics Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Spine Biologics Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Spine Biologics Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Spine Biologics Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Spine Biologics Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Spine Biologics Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Spine Biologics Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Spine Biologics Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Spine Biologics Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Spine Biologics Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Spine Biologics Sales Share by Manufacturer (2020-2025)
 Table 18. Spine Biologics Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Spine Biologics Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Spine Biologics Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Spine Biologics Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Spine Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2024)
 Table 24. Spine Biologics Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Spine Biologics Market
 Table 26. Manufacturers Spine Biologics Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Medtronic Company Information
 Table 29. Medtronic Description and Business Overview
 Table 30. Medtronic Spine Biologics Product
 Table 31. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Medtronic Sales Proportion of Spine Biologics by Product in 2024
 Table 33. Medtronic Sales Proportion of Spine Biologics by Application in 2024
 Table 34. Medtronic Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 35. Medtronic Recent Developments
 Table 36. Depuy Synthes Company Information
 Table 37. Depuy Synthes Description and Business Overview
 Table 38. Depuy Synthes Spine Biologics Product
 Table 39. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Depuy Synthes Sales Proportion of Spine Biologics by Product in 2024
 Table 41. Depuy Synthes Sales Proportion of Spine Biologics by Application in 2024
 Table 42. Depuy Synthes Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 43. Depuy Synthes Recent Developments
 Table 44. Stryker Corporation Company Information
 Table 45. Stryker Corporation Description and Business Overview
 Table 46. Stryker Corporation Spine Biologics Product
 Table 47. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Stryker Corporation Sales Proportion of Spine Biologics by Product in 2024
 Table 49. Stryker Corporation Sales Proportion of Spine Biologics by Application in 2024
 Table 50. Stryker Corporation Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 51. Stryker Corporation Recent Developments
 Table 52. Nuvasive Company Information
 Table 53. Nuvasive Description and Business Overview
 Table 54. Nuvasive Spine Biologics Product
 Table 55. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Nuvasive Sales Proportion of Spine Biologics by Product in 2024
 Table 57. Nuvasive Sales Proportion of Spine Biologics by Application in 2024
 Table 58. Nuvasive Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 59. Nuvasive Recent Developments
 Table 60. Zimmer Biomet Company Information
 Table 61. Zimmer Biomet Description and Business Overview
 Table 62. Zimmer Biomet Spine Biologics Product
 Table 63. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Zimmer Biomet Sales Proportion of Spine Biologics by Product in 2024
 Table 65. Zimmer Biomet Sales Proportion of Spine Biologics by Application in 2024
 Table 66. Zimmer Biomet Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 67. Zimmer Biomet Recent Developments
 Table 68. Orthofix International Company Information
 Table 69. Orthofix International Description and Business Overview
 Table 70. Orthofix International Spine Biologics Product
 Table 71. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Orthofix International Sales Proportion of Spine Biologics by Product in 2024
 Table 73. Orthofix International Sales Proportion of Spine Biologics by Application in 2024
 Table 74. Orthofix International Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 75. Orthofix International Recent Developments
 Table 76. Globus Medical Company Information
 Table 77. Globus Medical Description and Business Overview
 Table 78. Globus Medical Spine Biologics Product
 Table 79. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Globus Medical Sales Proportion of Spine Biologics by Product in 2024
 Table 81. Globus Medical Sales Proportion of Spine Biologics by Application in 2024
 Table 82. Globus Medical Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 83. Globus Medical Recent Developments
 Table 84. alphatec spine Company Information
 Table 85. alphatec spine Description and Business Overview
 Table 86. alphatec spine Spine Biologics Product
 Table 87. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. alphatec spine Sales Proportion of Spine Biologics by Product in 2024
 Table 89. alphatec spine Sales Proportion of Spine Biologics by Application in 2024
 Table 90. alphatec spine Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 91. alphatec spine Recent Developments
 Table 92. K2M Company Information
 Table 93. K2M Description and Business Overview
 Table 94. K2M Spine Biologics Product
 Table 95. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. K2M Sales Proportion of Spine Biologics by Product in 2024
 Table 97. K2M Sales Proportion of Spine Biologics by Application in 2024
 Table 98. K2M Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 99. K2M Recent Developments
 Table 100. Exactech Company Information
 Table 101. Exactech Description and Business Overview
 Table 102. Exactech Spine Biologics Product
 Table 103. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Exactech Sales Proportion of Spine Biologics by Product in 2024
 Table 105. Exactech Sales Proportion of Spine Biologics by Application in 2024
 Table 106. Exactech Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 107. Exactech Recent Developments
 Table 108. Wright Medical Technology Company Information
 Table 109. Wright Medical Technology Description and Business Overview
 Table 110. Wright Medical Technology Spine Biologics Product
 Table 111. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Wright Medical Technology Sales Proportion of Spine Biologics by Product in 2024
 Table 113. Wright Medical Technology Sales Proportion of Spine Biologics by Application in 2024
 Table 114. Wright Medical Technology Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 115. Wright Medical Technology Recent Developments
 Table 116. X-Spine Company Information
 Table 117. X-Spine Description and Business Overview
 Table 118. X-Spine Spine Biologics Product
 Table 119. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. X-Spine Sales Proportion of Spine Biologics by Product in 2024
 Table 121. X-Spine Sales Proportion of Spine Biologics by Application in 2024
 Table 122. X-Spine Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 123. X-Spine Recent Developments
 Table 124. Nutech Company Information
 Table 125. Nutech Description and Business Overview
 Table 126. Nutech Spine Biologics Product
 Table 127. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Nutech Sales Proportion of Spine Biologics by Product in 2024
 Table 129. Nutech Sales Proportion of Spine Biologics by Application in 2024
 Table 130. Nutech Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 131. Nutech Recent Developments
 Table 132. Arthrex Company Information
 Table 133. Arthrex Description and Business Overview
 Table 134. Arthrex Spine Biologics Product
 Table 135. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 136. Arthrex Sales Proportion of Spine Biologics by Product in 2024
 Table 137. Arthrex Sales Proportion of Spine Biologics by Application in 2024
 Table 138. Arthrex Sales Proportion of Spine Biologics by Geographic Area in 2024
 Table 139. Arthrex Recent Developments
 Table 140. North America Spine Biologics Sales by Country (2020-2025) & (K Units)
 Table 141. North America Spine Biologics Sales by Country (2026-2031) & (K Units)
 Table 142. North America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 143. North America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 144. North America Spine Biologics Sales by Type (2020-2025) & (K Units)
 Table 145. North America Spine Biologics Sales by Application (2020-2025) & (K Units)
 Table 146. Asia-Pacific Spine Biologics Sales by Region (2020-2025) & (K Units)
 Table 147. Asia-Pacific Spine Biologics Sales by Region (2026-2031) & (K Units)
 Table 148. Asia-Pacific Spine Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 149. Asia-Pacific Spine Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 150. Asia-Pacific Spine Biologics Sales by Type (2020-2025) & (K Units)
 Table 151. Asia-Pacific Spine Biologics Sales by Application (2020-2025) & (K Units)
 Table 152. Europe Spine Biologics Sales by Country (2020-2025) & (K Units)
 Table 153. Europe Spine Biologics Sales by Country (2026-2031) & (K Units)
 Table 154. Europe Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 155. Europe Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 156. Europe Spine Biologics Sales by Type (2020-2025) & (K Units)
 Table 157. Europe Spine Biologics Sales by Application (2020-2025) & (K Units)
 Table 158. Latin America Spine Biologics Sales by Country (2020-2025) & (K Units)
 Table 159. Latin America Spine Biologics Sales by Country (2026-2031) & (K Units)
 Table 160. Latin America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 161. Latin America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 162. Latin America Spine Biologics Sales by Type (2020-2025) & (K Units)
 Table 163. Latin America Spine Biologics Sales by Application (2020-2025) & (K Units)
 Table 164. Middle East and Africa Spine Biologics Sales by Country (2020-2025) & (K Units)
 Table 165. Middle East and Africa Spine Biologics Sales by Country (2026-2031) & (K Units)
 Table 166. Middle East and Africa Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 167. Middle East and Africa Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 168. Middle East and Africa Spine Biologics Sales by Type (2020-2025) & (K Units)
 Table 169. Middle East and Africa Spine Biologics Sales by Application (2020-2025) & (K Units)
 Table 170. Spine Biologics Key Raw Materials, Industry Status and Trend
 Table 171. Spine Biologics Key Raw Materials and Upstream Suppliers
 Table 172. Spine Biologics Clients Status and Trend
 Table 173. Spine Biologics Typical Clients
 Table 174. Spine Biologics Distributors
 Table 175. Spine Biologics Market Trends
 Table 176. Spine Biologics Market Drivers
 Table 177. Spine Biologics Market Challenges
 Table 178. Spine Biologics Market Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources
 Table 182. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Spine Biologics Product Picture
 Figure 2. Global Spine Biologics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Spine Biologics Sales Market Share by Type in 2024 & 2031
 Figure 4. Bone Graft Product Picture
 Figure 5. Bone Graft Substitute Product Picture
 Figure 6. Platelet Rich Plasma (PRP) Product Picture
 Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
 Figure 8. Global Spine Biologics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Spine Biologics Sales Market Share by Application in 2024 & 2031
 Figure 10. Anterior Cervical Discectomy and Fusion
 Figure 11. Posterior Lumbar Interbody Fusion
 Figure 12. Others
 Figure 13. Spine Biologics Report Years Considered
 Figure 14. Global Spine Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Spine Biologics Market Size 2020-2031 (US$ Million)
 Figure 16. Global Spine Biologics Sales 2020-2031 (K Units)
 Figure 17. Global Spine Biologics Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Spine Biologics Revenue Market Share by Region (2020-2031)
 Figure 19. Global Spine Biologics Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Spine Biologics Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Spine Biologics Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 22. Global Spine Biologics Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Spine Biologics Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Spine Biologics Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 25. Bone Graft of Spine Biologics Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Bone Graft Substitute of Spine Biologics Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Platelet Rich Plasma (PRP) of Spine Biologics Revenue Market Share by Application, 2024 VS 2031
 Figure 28. BMAC (Bone Marrow Aspirate Concentrate) of Spine Biologics Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Global Spine Biologics Sales Share by Manufacturer in 2024
 Figure 30. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Bone Graft Market Sales Proportion by Manufacturer in 2024
 Figure 32. Bone Graft Substitute Market Sales Proportion by Manufacturer in 2024
 Figure 33. Platelet Rich Plasma (PRP) Market Sales Proportion by Manufacturer in 2024
 Figure 34. BMAC (Bone Marrow Aspirate Concentrate) Market Sales Proportion by Manufacturer in 2024
 Figure 35. North America Spine Biologics Revenue 2020-2031 (US$ Million)
 Figure 36. North America Spine Biologics Sales Market Share by Type (2020-2025)
 Figure 37. North America Spine Biologics Sales Market Share by Application (2020-2025)
 Figure 38. Asia-Pacific Spine Biologics Revenue 2020-2031 (US$ Million)
 Figure 39. Asia-Pacific Spine Biologics Sales Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Spine Biologics Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Spine Biologics Sales Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Spine Biologics Sales Market Share by Application (2020-2025)
 Figure 43. Europe Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Spine Biologics Sales Market Share by Country (2020-2031)
 Figure 45. Europe Spine Biologics Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Spine Biologics Sales Market Share by Type (2020-2025)
 Figure 47. Europe Spine Biologics Sales Market Share by Application (2020-2025)
 Figure 48. Latin America Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Spine Biologics Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Spine Biologics Revenue Market Share by Country (2020-2025)
 Figure 51. Latin America Spine Biologics Sales Market Share by Type (2020-2025)
 Figure 52. Latin America Spine Biologics Sales Market Share by Application (2020-2025)
 Figure 53. Middle East and Africa Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Middle East and Africa Spine Biologics Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Spine Biologics Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Spine Biologics Sales Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Spine Biologics Sales Market Share by Application (2020-2025)
 Figure 58. Spine Biologics Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Spine Biologics Raw Materials by Region in 2024
 Figure 60. Spine Biologics Distribution Channels
 Figure 61. Global Spine Biologics Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Spine Biologics Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS